{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:38:39Z","timestamp":1790933919356,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7762","license":[{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1038\/s41586-019-1252-x","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T18:03:01Z","timestamp":1559152981000},"page":"474-479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":115,"title":["Growth dynamics in naturally progressing chronic lymphocytic leukaemia"],"prefix":"10.1038","volume":"570","author":[{"given":"Michaela","family":"Gruber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Bozic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignaty","family":"Leshchiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Livitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rassenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rosebrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaro","family":"Taylor-Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Olive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reaha","family":"Goyetche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey M.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chip","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Cibulskis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wandi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes G.","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Gerold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Gribben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanti R.","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Neuberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Kipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad","family":"Getz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,29]]},"reference":[{"key":"1252_CR1","doi-asserted-by":"crossref","unstructured":"Wodarz, D. & Komarova, N. L. Dynamics of Cancer: Mathematical Foundations Of Oncology (World Scientific, 2014).","DOI":"10.1142\/8973"},{"key":"1252_CR2","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11589","volume":"7","author":"JA Burger","year":"2016","unstructured":"Burger, J. A. et al. Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition. Nat. Commun. 7, 11589 (2016).","journal-title":"Nat. Commun."},{"key":"1252_CR3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature11219","volume":"486","author":"LA Diaz Jr.","year":"2012","unstructured":"Diaz, L. A. Jr. et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 486, 537\u2013540 (2012).","journal-title":"Nature"},{"key":"1252_CR4","first-page":"7067","volume":"48","author":"L Norton","year":"1988","unstructured":"Norton, L. A Gompertzian model of human breast cancer growth. Cancer Res. 48, 7067\u20137071 (1988).","journal-title":"Cancer Res."},{"key":"1252_CR5","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/1097-0142(19930315)71:6<2013::AID-CNCR2820710615>3.0.CO;2-V","volume":"71","author":"JA Spratt","year":"1993","unstructured":"Spratt, J. A., von Fournier, D., Spratt, J. S. & Weber, E. E. Decelerating growth and human breast cancer. Cancer 71, 2013\u20132019 (1993).","journal-title":"Cancer"},{"key":"1252_CR6","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9305","volume":"6","author":"S Misale","year":"2015","unstructured":"Misale, S. et al. Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers. Nat. Commun. 6, 8305 (2015).","journal-title":"Nat. Commun."},{"key":"1252_CR7","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1007\/s11538-015-0110-8","volume":"77","author":"A Talkington","year":"2015","unstructured":"Talkington, A. & Durrett, R. Estimating tumor growth rates in vivo. Bull. Math. Biol. 77, 1934\u20131954 (2015).","journal-title":"Bull. Math. Biol."},{"key":"1252_CR8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.tree.2013.05.020","volume":"28","author":"IA Rodriguez-Brenes","year":"2013","unstructured":"Rodriguez-Brenes, I. A., Komarova, N. L. & Wodarz, D. Tumor growth dynamics: insights into evolutionary processes. Trends Ecol. Evol. 28, 597\u2013604 (2013).","journal-title":"Trends Ecol. Evol."},{"key":"1252_CR9","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1158\/0008-5472.CAN-12-4355","volume":"73","author":"P Gerlee","year":"2013","unstructured":"Gerlee, P. The model muddle: in search of tumor growth laws. Cancer Res. 73, 2407\u20132411 (2013).","journal-title":"Cancer Res."},{"key":"1252_CR10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/bjc.1998.503","volume":"78","author":"D Hart","year":"1998","unstructured":"Hart, D., Shochat, E. & Agur, Z. The growth law of primary breast cancer as inferred from mammography screening trials data. Br. J. Cancer 78, 382\u2013387 (1998).","journal-title":"Br. J. Cancer"},{"key":"1252_CR11","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","volume":"131","author":"M Hallek","year":"2018","unstructured":"Hallek, M. et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood 131, 2745\u20132760 (2018).","journal-title":"Blood"},{"key":"1252_CR12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature14666","volume":"526","author":"XS Puente","year":"2015","unstructured":"Puente, X. S. et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature 526, 519\u2013524 (2015).","journal-title":"Nature"},{"key":"1252_CR13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","volume":"526","author":"DA Landau","year":"2015","unstructured":"Landau, D. A. et al. Mutations driving CLL and their evolution in progression and relapse. Nature 526, 525\u2013530 (2015).","journal-title":"Nature"},{"key":"1252_CR14","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","volume":"365","author":"L Wang","year":"2011","unstructured":"Wang, L. et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N. Engl. J. Med. 365, 2497\u20132506 (2011).","journal-title":"N. Engl. J. Med."},{"key":"1252_CR15","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","volume":"152","author":"DA Landau","year":"2013","unstructured":"Landau, D. A. et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 152, 714\u2013726 (2013).","journal-title":"Cell"},{"key":"1252_CR16","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"H D\u00f6hner","year":"2000","unstructured":"D\u00f6hner, H. et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N. Engl. J. Med. 343, 1910\u20131916 (2000).","journal-title":"N. Engl. J. Med."},{"key":"1252_CR17","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin, T. J., Davis, Z., Gardiner, A., Oscier, D. G. & Stevenson, F. K. Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94, 1848\u20131854 (1999).","journal-title":"Blood"},{"key":"1252_CR18","doi-asserted-by":"crossref","unstructured":"Leshchiner, I. et al. Comprehensive analysis of tumour initiation, spatial and temporal progression under multiple lines of treatment. Preprint at https:\/\/www.bioRxiv.org\/content\/10.1101\/508127v2 (2018).","DOI":"10.1101\/508127"},{"key":"1252_CR19","doi-asserted-by":"crossref","first-page":"e1004731","DOI":"10.1371\/journal.pcbi.1004731","volume":"12","author":"I Bozic","year":"2016","unstructured":"Bozic, I., Gerold, J. M. & Nowak, M. A. Quantifying clonal and subclonal passenger mutations in cancer evolution. PLOS Comput. Biol. 12, e1004731 (2016).","journal-title":"PLOS Comput. Biol."},{"key":"1252_CR20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/ng.3489","volume":"48","author":"MJ Williams","year":"2016","unstructured":"Williams, M. J., Werner, B., Barnes, C. P., Graham, T. A. & Sottoriva, A. Identification of neutral tumor evolution across cancer types. Nat. Genet. 48, 238\u2013244 (2016).","journal-title":"Nat. Genet."},{"key":"1252_CR21","doi-asserted-by":"crossref","unstructured":"Wang, J. et al. Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia. eLife 3,\u00a0e02869 (2014).","DOI":"10.7554\/eLife.02869"},{"key":"1252_CR22","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1470-2045(16)30029-8","volume":"17","author":"The International CLL-IPI working group","year":"2016","unstructured":"The International CLL-IPI working group. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data. Lancet Oncol. 17, 779\u2013790 (2016).","journal-title":"Lancet Oncol."},{"key":"1252_CR23","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1182\/blood-2014-06-580563","volume":"125","author":"J Ojha","year":"2015","unstructured":"Ojha, J. et al. Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia. Blood 125, 492\u2013498 (2015).","journal-title":"Blood"},{"key":"1252_CR24","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/leu.2016.10","volume":"30","author":"MJJ Rose-Zerilli","year":"2016","unstructured":"Rose-Zerilli, M. J. J. et al. Longitudinal copy number, whole exome and targeted deep sequencing of \u2018good risk\u2019 IGHV-mutated CLL patients with progressive disease. Leukemia 30, 1301\u20131310 (2016).","journal-title":"Leukemia"},{"key":"1252_CR25","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2015.14","volume":"5","author":"EN Smith","year":"2015","unstructured":"Smith, E. N. et al. Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell development. Blood Cancer J. 5, e303 (2015).","journal-title":"Blood Cancer J."},{"key":"1252_CR26","volume":"7","author":"P Martinez","year":"2016","unstructured":"Martinez, P. et al. Dynamic clonal equilibrium and predetermined cancer risk in Barrett\u2019s oesophagus. Nat. Commun. 7, 12158 (2016).","journal-title":"Nat. Commun."},{"key":"1252_CR27","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1038\/leu.2014.226","volume":"28","author":"J Ojha","year":"2014","unstructured":"Ojha, J. et al. Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression. Leukemia 28, 2395\u20132398 (2014).","journal-title":"Leukemia"},{"key":"1252_CR28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/leu.2016.172","volume":"31","author":"S Barrio","year":"2017","unstructured":"Barrio, S. et al. Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome. Leukemia 31, 170\u2013176 (2017).","journal-title":"Leukemia"},{"key":"1252_CR29","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1182\/blood-2012-05-433540","volume":"120","author":"A Schuh","year":"2012","unstructured":"Schuh, A. et al. Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns. Blood 120, 4191\u20134196 (2012).","journal-title":"Blood"},{"key":"1252_CR30","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/leu.2012.14","volume":"26","author":"E Braggio","year":"2012","unstructured":"Braggio, E. et al. Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse. Leukemia 26, 1698\u20131701 (2012).","journal-title":"Leukemia"},{"key":"1252_CR31","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1158\/1078-0432.CCR-15-3103","volume":"22","author":"NA Amin","year":"2016","unstructured":"Amin, N. A. et al. A Quantitative analysis of subclonal and clonal gene mutations before and after therapy in chronic lymphocytic leukemia. Clin. Cancer Res. 22, 4525\u20134535 (2016).","journal-title":"Clin. Cancer Res."},{"key":"1252_CR32","doi-asserted-by":"crossref","unstructured":"Tabak, B. et al. The Tangent copy-number inference pipeline for cancer genome analyses. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/566505v1 (2019).","DOI":"10.1101\/566505"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1252-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1252-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1252-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:56:04Z","timestamp":1684619764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-019-1252-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,29]]},"references-count":32,"journal-issue":{"issue":"7762","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1252"],"URL":"https:\/\/doi.org\/10.1038\/s41586-019-1252-x","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,29]]},"assertion":[{"value":"26 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.J.W. is founder of Neon Therapeutics and a member of its scientific advisory board. G.G. receives research funds from IBM and Pharmacyclics. G.G. is an inventor of several bioinformatics-related patents, including patents\u00a0related to MuTect and ABSOLUTE. C.J.W., D.N. and T.J.K. receive research funding from Pharmacyclics. J.S. is a current employee of Moderna Therapeutics. J.G.G. receives grant funding from Janssen, Acerta, Celgene; and received honoraria from Abbvie, AZ, Celgene, Kite, Janssen, Pharmacyclics, Roche and Novartis. K.R.R. is on Medical Advisory Boards of Pharmacyclics, Roche\/Genentech and Cellectis. J.R.B. is a consultant for Abbvie, Acerta, Beigene, Genentech\/Roche, Gilead, Juno\/Celgene, Kite, Loxo, Novartis, Pfizer, Pharmacyclics, Sunesis, TG Therapeutics and Verastem; received honoraria from Janssen and Teva; received research funding from Gilead, Loxo, Sun and Verastem; and served on data safety monitoring committees for Morphosys and Invectys. The other authors declare no potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}